SEC Filings | Madrigal Pharmaceuticals.

Filing date	Form	Description	View
December 13, 2023	SC 13D/A	An amendment to a SC 13D filing	0001193125-23-294326.pdf 0001193125-23-294326.rtf 0001193125-23-294326.xls
December 11, 2023	4	Statement of changes in beneficial ownership of securities	0000899243-23-020582.pdf 0000899243-23-020582.rtf 0000899243-23-020582.xls
December 08, 2023	CORRESP	CORRESP	0001193125-23-291715.pdf 0001193125-23-291715.rtf
December 06, 2023	4	Statement of changes in beneficial ownership of securities	0000950170-23-068575.pdf 0000950170-23-068575.rtf 0000950170-23-068575.xls
December 01, 2023	4	Statement of changes in beneficial ownership of securities	0000950170-23-067360.pdf 0000950170-23-067360.rtf 0000950170-23-067360.xls
November 22, 2023	4	Statement of changes in beneficial ownership of securities	0000950170-23-065902.pdf 0000950170-23-065902.rtf 0000950170-23-065902.xls
November 22, 2023	3	Initial filing by director officer or owner of more than ten percent	0000950170-23-065900.pdf 0000950170-23-065900.rtf 0000950170-23-065900.xls
November 21, 2023	SC 13D/A	An amendment to a SC 13D filing	0001104659-23-120429.pdf 0001104659-23-120429.rtf 0001104659-23-120429.xls
November 21, 2023	4	Statement of changes in beneficial ownership of securities	0001209191-23-056363.pdf 0001209191-23-056363.rtf 0001209191-23-056363.xls
November 21, 2023	4	Statement of changes in beneficial ownership of securities	0001209191-23-056364.pdf 0001209191-23-056364.rtf 0001209191-23-056364.xls

Data provided by Kaleidoscope.